baber/WOPTO huggingface dataset:
Patent WO-2007109089-A9 (WO)
Inventor: MARKLEY JEFFREY P
IPC: H04L12/56
Filed: 2007-03-14
Abstract: Methods and apparatus for centralized content, media and data delivery and access within a premises such as, e.g., a residence. In one embodiment, the apparatus comprises a remotely manageable premises device that acts as a centralized client networking platform, providing gateway services such as network management as well as traditional content and high-speed data delivery functions. The device also acts as the shared internet connection for all devices in the premises via a cable modem, sharing personal and DVR content such as video, music and photos (and any associated metadata) throughout the premises, and providing both a wired and wireless network in the home. Telephony services utilizing e.g., embedded multimedia terminal adapter (eMTA) and/or Wi-Fi architectures may also be provided via the device. The device can also provide a trusted domain for content or data, as well as allowing a subscriber total mobility in the home.
Patent WO-2007139852-A9 (WO)
Inventor: HAUENSTEIN HENNING M
IPC: H01L23/52
Filed: 2007-05-23
Abstract: Deux plaquettes DBC côtés possèdent des surfaces conductrices à motif qui reçoivent une puce semi-conductrice prise en sandwich. Un réseau de conducteurs s'étendant à l'intérieur du boîtier sont connectés aux bornes de la puce. Les surfaces conductrices extérieures de chacune des plaquettes permettent un refroidissement du semiconducteur par les deux côtés.
Patent WO-2008051616-A9 (WO)
Title: Nanomatières hybrides organiques/inorganiques et leur procédé de synthèse
Inventor: BRITTAIN WILLIAM J
IPC: B82B3/00
Filed: 2007-10-26
Abstract: L'invention concerne des nanomatières hybrides organiques/inorganiques et leurs procédés de synthèse. Dans un mode de réalisation, l'invention concerne des nanomatières hybrides comprenant une partie inorganique (par exemple, des particules inorganiques, notamment des particules de silice) enrobée/recouverte d'au moins un composé polymère (à savoir la partie organique); et des procédés de synthèse de telles nanomatières hybrides. Dans un autre mode de réalisation, l'invention concerne des nanomatières hybrides comprenant une partie inorganique (par exemple, des particules inorganiques, notamment des particules de silice) présentant au moins un polymère ou des parties polymères (à savoir, la partie organique) greffées et/ou fixées sur la partie inorganique; et des procédés de synthèse de telles nanomatières hybrides.
Patent WO-2008095021-A9 (WO)
Title: Free form voice command model interface for ivr navigation
Inventor: VEMURI SUNIL
IPC: G10L11/00
Filed: 2008-01-30
Abstract: A method and system for dynamically presenting command prompts in the call flow of an integrated voice response application are disclosed. Accordingly, a single top-level command prompt is presented, and based on an analysis of a spoken command and a variable number of command parameters received from a user, an additional confirmation prompt or command prompt may be selected and presented.
Patent WO-2008109472-A9 (WO)
Title: Composés d'acide nucléique pour inhiber l'expression du gène pcsk9 et utilisations de ceux-ci
Inventor: QUAY STEVEN C
IPC: A61K31/7088
Filed: 2008-02-29
Abstract: L'invention concerne des molécules d'acide ribonucléique méroduplex (ARNmd) pouvant diminuer ou étouffer l'expression du gène PCSK9. Un ARNmd de cette description comprend au moins trois brins qui s'associent pour former au moins deux régions double brin non chevauchantes séparées par une encoche ou un espace dans lequel un brin est complémentaire à un ARNm PCSK9. De plus, le méroduplex peut avoir au moins une uridine qui est une 5-méthyluridine, un nucléoside qui est un acide nucléique bloqué, ou éventuellement d'autres modifications, et toute combinaison de ceux-ci. Sont également proposés des procédés de diminution de l'expression d'un gène PCSK9 dans une cellule ou chez un sujet pour traiter une maladie liée au PCSK9.
Patent WO-2011150226-A9 (WO)
Title: Procédé de détection d'acides nucléiques en fonction de formation d'agrégats
Inventor: LANDERS JAMES P
IPC: C12Q1/68
Filed: 2011-05-26
Abstract: L'invention concerne des procédés de détection ou de détermination de la présence ou de la quantité d'un pathogène, tel qu'un virus ou une bactérie, dans un échantillon, ou de la quantité de cellules en fonction de la détection de leur ADN génomique. Le procédé utilise des substrats magnétiques et soumet l'échantillon et les substrats magnétiques à des formes d'énergie afin d'induire la formation d'agrégats et de détecter les agrégats.
Patent WO-2014004944-A9 (WO)
Inventor: BRAIDO PETER N
IPC: A61F2/24
Filed: 2013-06-28
Abstract: A method of assembling a prosthetic heart valve (100) includes providing a collapsible and expandable stent (102) having an annulus section (110) and an aortic section (111). The annulus section has a first diameter in a relaxed condition and a second diameter less than the first diameter in a collapsed condition. A constraint (510) is applied to the stent to constrain the annulus section to a predetermined diameter between the first and second diameters. Applying a cuff (106) and/or a plurality of leaflets (108) to the stent in the constrained condition enables less material to be used. The resultant prosthetic valve is therefore able to be collapsed to a smaller diameter for introduction into a patient.
Patent WO-2014152145-A9 (WO)
Title: Procédés de production d'anticorps
Inventor: XING ZIZHUO
IPC: C12P21/08
Filed: 2014-03-14
Abstract: La présente invention concerne un procédé de production d'anticorps dans  Pichia pastoris , tel que par fermentation semi-discontinue. Le procédé comprend une vérification du quotient respiratoire afin de surveiller le profil d'éthanol et améliorer la qualité de l'anticorps par, notamment, une suppression du clivage de la chaîne lourde. Le procédé peut également comprendre une stratégie consistant à augmenter la concentration d'éthanol à environ 18-22 g/L puis à maintenir le taux d'éthanol à environ 5-17 g/L pour stabiliser la masse cellulaire et augmenter le taux de production de l'anticorps. Le procédé peut également comprendre l'ajout d'environ 2,0 - 5,0 g/L d'hydroxyurée pendant le processus de fermentation afin de maintenir une densité cellulaire constante et augmenter le titre total du milieu de culture de l'anticorps.
Patent WO-2015081294-A9 (WO)
Inventor: BRUECK STEVEN R J
IPC: B01L7/00
Filed: 2014-11-26
Abstract: L'invention concerne des procédés et un appareil pour un séquençage optique de molécules à chaîne longue par nanopores à lecture longue et sans marqueurs. De façon générale, la présente invention décrit une technologie de séquençage innovante basée sur l'intégration de nanocanaux pour délivrer des molécules à chaîne longue individuelles avec des nanopores « tortueux » à espacement large (> longueur d'onde) à ouverture de 1 nm, qui ralentissent suffisamment la translocation pour fournir une résolution de base unique massivement parallèle à l'aide de techniques optiques. Un modèle innovant de nanofabrication par auto-assemblage dirigé utilisant de simples nanoparticules colloïdales est utilisé pour former les matrices de nanopores au-dessus de nanocanaux qui déplient les molécules à chaîne longue. A la surface de la matrice de nanoparticules, des champs électromagnétiques fortement localisés dans des structures plasmoniques/polaritoniques artificielles permettent d'obtenir une résolution de base unique à l'aide de techniques optiques.
Patent WO-2019191500-A9 (WO)
Title: Kinematic bra for posture recovery and thoracic mobility
Inventor: LIU STEPHEN
IPC: A61F5/03
Filed: 2019-03-28
Abstract: A therapeutic posture correcting and chest expanding bra invention for improving posture and thoracic mobility, including a method of manufacture thereof in the posture recovery, chest expansion, shoulder and spine muscle rehabilitation, occupation risk prevention, anti-aging posture training and athletic enhancement space. A bra that is uniquely designed, manufactured and fabric woven to improve scapular kinematics and spinal biomechanics, and overall proprioceptive posture rebalance, correction and comfort that allows for breathability, functionality, range of motion, and a fashionable nature. The kinematic bra is uniquely designed and narrows the distance between the scapulae with proprioceptive shoulder muscle relaxation and spinal muscle activation, and, secondarily, allows for chest expansion to provide better breathing and overall improvement of women's health and wellness.
Patent WO-2021257830-A9 (WO)
Inventor: KAHVEJIAN AVAK
IPC: C12Q1/6844
Filed: 2021-06-17
Abstract: This invention relates generally to compositions and methods for administering an anellovector (e.g., a synthetic anellovector) that can be used as a delivery vehicle, e.g., for delivering genetic material, for delivering an effector, e.g., a payload, or for delivering a therapeutic agent or a therapeutic effector to a eukaryotic cell (e.g., a human cell or a human tissue). Also provided are methods for amplifying circular nucleic acids comprising Anellovirus sequences.
Patent WO-2022072532-A9 (WO)
Inventor: FINI ELHAM
IPC: C08K3/06
Filed: 2021-09-29
Abstract: Selon l'invention, la formation d'un bitume modifié comprend la mise en contact d'une huile avec du bitume pour produire une matrice bitumineuse comprenant l'huile, la combinaison du soufre avec la matrice bitumineuse, et la réaction du soufre avec l'huile pour produire le bitume modifié. La composition de bitume modifiée comprend du bitume, un composant soufre et un composant huile. Le composant soufre est lié par covalence au composant huile, et le composant huile est lié par covalence au bitume. Un asphalte peut comprendre le bitume modifié.
Patent CS-212664-B1 (CS)
Inventor: SEDLECKY VACLAV
IPC: D03C1/14
Filed: 1980-01-08
Abstract: Vynález se týká zapojení pro řízení
listového stroje mikropočítače.
Podstata vynálezu spočívá,,v tom, 2e
mikropočítač je propojen alespoň s jedním
výstupem synchronizačního obvodu, propojeného
mechanickým spojením s hřídelem listového
stroje nebo tkacího stroje a pomocí
sběmic je mikropočítač epojen přes oddělovací
člen β elektromechanickým převodníkem.
Patent CS-214499-B1 (CS)
Inventor: KUNIAK LUDOVIT
IPC: C08B15/00
Filed: 1981-01-09
Abstract: Vynález rieši spfisob přípravy mikrokryštalickej
celulózy, ktorý má použitie
vo/farmaceutickom priemysle.
Podstata vynálezu spočívá v tom, že
mikrokryštalická celulóza získaná kyslou
heterogénnou hydrolýzou natívnyoh celulóz
sa podrobí po hydrolýze mokrej defibráoii
a v druhom stupni defibrovaná mikrokryštalická
celulóza sa odfiltruje a vysuší a
v treVom stupni sa vysušená mikrokryštalická
celulóza defibruje a nakoniec sa defibrovaný
produkt frakcionuje.
Vynález má použitie vo farmaceutiokom
priemysle pri suchom tabletovaní liekov
a v potravinárskom priemysle pri přípravě
majonéz, pudingov, zmrzliny a iných
potravinářských produktov.
Patent IE-51562-B1 (IE)
Title: Improvements in or relating to telecommunications exchanges
IPC: H04Q11/04
Filed: 1981-02-19
Abstract: A digital telephone exchange including a first and second processor in which the second processor contains algorithms selectable by the first processor for operation of functions within the exchange, and in which subscribers' apparatus is connectable to both processors via bus structures and in which signals are passed along the bus structures between connected subscribers under the command of both processors.
Patent IE-38917-B1 (IE)
Title: Isoquinoline derivatives and process for their manufactur
IPC: C07D217/24
Filed: 1974-02-22
Abstract: 1457186 Therapeutic compositions HOECHST AG 22 Feb 1974 [24 Feb 1973] 8171/74 Heading A5B [Also in Division C2] Therapeutic compositions having hypolipaemic and (in some cases) hypoglycaemic activity and which are preferably administered orally, comprise (with certain exclusions: see Division C2) compounds of formula wherein X is O or S; R<SP>1</SP> is H, C 1-6 alkyl or Ph; R<SP>2</SP> is H, or R<SP>1</SP>-R<SP>2</SP> forms with the ring 4-C atom a carbocyclic 5- or 6-membered ring; R<SP>3</SP>, R<SP>4</SP>, R<SP>5</SP> are each H, halogen or NO 2 ; and R<SP>6</SP>, R<SP>7</SP> are each H or C 1-4 alkoxy. Other pharmaceutically active substances which may be present are antidiabetics such as glycodiazin, tolbutamide, glibenclamide, phenformin, buformin and metformin; circulatory agents such as chromonar and prenylamine; hypotensives such as reserpin, alpha-methyldopa and clonidines; other hypolipaemics; geriatric agents; psycho-pharmaceuticals such as chlordiazepoxide, diazepan or meprobamate; and vitamins.
[GB1457186A]
Patent IE-39021-B1 (IE)
Title: Compression impregnation of wood veneers
IPC: B27K3/02
Filed: 1974-02-28
Abstract: Wood veneers are compression treated by passing the veneers between compression rollers while submerged in a treating solution. The veneers are passed between the rollers in multiple layers with the direction of feed being parallel to the grain or cell orientation of the veneers. The veneers have an original moisture content above the fiber saturation point and are compressed to about one-half their original thickness.
[US3950577A]
Patent IE-54859-B1 (IE)
Title: Tricyclic derivatives of 5,6-dihydro-11h-dibenzo(b,e)-azepin-6-one having pharmacological activity, and relative production methods
IPC: C07D223/20
Filed: 1983-03-14
Abstract: A pharmacologically active compound has the general formulain which R is a hydrogen atom or an alkyl group containing from 1 to 4 carbon atoms; R, and R<sub>2</sub>, which can be different, represent a hydrogen atom, a hydroxyl group, an alkyl group, an alkoxy group, an arylalkyl group, or an arylalkoxy group, or can jointly represent an oxygen atom or a CHCOOR,' group where R<sub>1</sub>' is a hydrogen atom or an alkyl group; and R<sub>3</sub> represents a hydrogen or halogen atom or an alkyl, NH<sub>2</sub>, NO<sub>2</sub>, NHCO-alkyl, NHCO-aryl, NHCONH-alkyl or NHCONH-aryl group.These compounds act on the central nervous system and have an anti-convulsant sedative activity.
Patent IE-51037-B1 (IE)
Title: Continuous polymerization process for preparing polymers and copolymers of ethylenically unsaturated water-soluble monomers
IPC: C08F2/10
Filed: 1981-03-20
Abstract: Continuous process for the preparation of watersoluble polymers in which highly concentrated monomer solutions may be polymerized by a combination of a visible light and a thermally initiated process.
Patent IE-33120-B1 (IE)
Title: A method and apparatus for feeding shredded cellulose pulp to a disintegrator
IPC: D04H1/425
Filed: 1969-05-26
Abstract: Method and apparatus are provided for converting sheet cellulose pulp to defibrated pulp, uniformity of the defibrated pulp stock being ensured by pooling the shredded pulp obtained from a plurality of cellulose pulp sheets, and uniformly feeding the pooled shredded pulp fibers to the disintegrators.
[US3645456A]
Patent IE-33283-B1 (IE)
Title: N-arallyl-n'-aralkyl piperazines and pharmaceutical compositions thereof
IPC: C07D295/04
Filed: 1969-06-09
Abstract: 1,268,710. Fluoro-substituted N-cinnamyl-N<SP>1</SP>- benzhydryl piperazine. JANSSEN PHARMACEUTICA N.V. 10 June 1969 [2 July, 1968], No. 29382/69. Heading C2C. Novel fluoro-substituted N-cinnamyl-N<SP>1</SP>- benzhydryl piperazines of the formula wherein each Ar may be a phenyl or fluorophenyl group, provided that at least one Ar is a fluorophenyl group, may be obtained by reacting a compound with a compound Y-CH 2 -CH=CH-Ar, where Y and Y<SP>1</SP> are different and represent a halogen atom or a piperazine residue, in the presence of a base and, if desired, forming a therapeutically active acid addition salt. Preparation of the following intermediates is also described: 1-(p-fluoro-α.-phenylbenzyl)-piperazine from p-fluoro-α-phenylbenzylchloride and piperazine; p-fluorocinnamylchloride from pfluoro-α-vinylbenzyl alcohol and HCl; di-(4- fluorophenyl)-chloromethane from α-(4-fluoro-phenyl)-4-fluorobenzyl alcohol and HCl. Pharmaceutical composition having anti-arrhythmic activity comprises a compound of Formula I above, or a therapeutically active acid addition salt thereof, in admixture with a pharmaceutically acceptable carrier, in forms suitable for oral or parenteral administration.
[GB1268710A]
Patent IE-35833-B1 (IE)
Title: Suspending liquids
IPC: C11D17/00
Filed: 1971-06-24
Abstract: 1308190 Aqueous detergent suspending liquids UNILEVER Ltd 25 June 1971 [26 June 1970] 31090/70 Heading C5D Aqueous detergent liquids for suspending particulate matter comprise (A) water, (B) a water-soluble anionic organic detergent, (C) an unionized amphiphilic compound wherein (C) is present in such an amount that the mixture of (A), (B) and (C) has an apparent viscosity of not less than 0À2 poise at 1100 seconds<SP>-1</SP> shear rate and not more than 3À5 poise at 7 seconds<SP>-1</SP> and has non-Newtonian flow character and (F) a polarizable organic agent soluble in dodecane to the extent of at least 10% by wt. at 25 C. and soluble in distilled water at 25 C. in the range 0À02 to 2% w/w., present in an amount such that the resulting liquid has a yield value of at least 2 dynes per sq. cm. measured in the shear rate range of 10<SP>-2</SP> to 10<SP>-4</SP> seconds<SP>-1</SP>. Optional additions are (D) an electrolyte and (E) a viscosity modifier. The liquids may comprise 5-35% of (B), 2-10% of (C), 0À5-10% of (D), 0À5-10% of (E) and 0À5- 5% of (F). Compounds (C) may be C 8 -C 14 fatty acids, C 8 -C 14 aliphatic alcohols, C 8 -C 14 alkylamines, amine oxides, sulphoxides and Zwitterionic surfactants. Compounds (D) are alkali metal halides, sulphates, carbonates, silicates and phosphates and organic substituted ammonium halides. Compounds (F) may be ethanol, methanol or diethylene glycol monoethyl ether. The liquids may be used to suspend silica, quartz, felspar, kaolin, carborundum or encapsulated material, e.g. encapsulated perfume. Specifications 882,569 and 955,081 are referred to.
[GB1308190A]
Patent IE-46804-B1 (IE)
Title: A method of bonding a bioglass to metal and product produced thereby
IPC: C23D5/04
Filed: 1978-04-25
Abstract: A method of bonding a bioglass layer to a metal substrate comprising heating the metal substrate having a roughened, oxidized surface to about a temperature at which the expansion of the metal is substantially equal to that of the bioglass at the temperature above which the thermal expansion of the bioglass is non-linear, immersing the heated metal surface in molten bioglass, the time of immersion being of such duration that the temperature of the metal does not rise substantially above the temperature to which it is heated, allowing the coated substrate to cool whereby the bioglass layer is bonded to the metal substrate by ion diffusion and thermo-mechanical stresses in the bioglass and metal layer are relieved at a substantially equal rate and the product produced by said process.
Patent IE-33170-B1 (IE)
Title: Aminoalkane carboxylic acids,process for their manufacture and compositions containing such compounds
IPC: H02K3/32
Filed: 1969-06-23
Abstract: 1278790 Hypotensive &c compositions C1- BA-GEIGY AG 23 June 1969 [24 June 1968] 31508/69 Heading A5B [Also in Division C2] Pharmaceutical compositions in conventional forms for oral or parenteral administration and having hypotensive and sedative activity comprise a #-amino-#-(hydroxyphenyl) alkane carboxylic acid of formula I: wherein R 1 and R 2 are each H or C 1- alkyl R 3 is H, OH, CF 3 , C 1-7 alkyl, C 1-7 alkoxy or halogen and n is 1 or 2 or a salt thereof and a solid or liquid pharmaceutical carrier which except for the compounds of formula I which are novel (see Division C2) does not include non-sterile water and organic solvents used for the preparation of the shown compounds, and optionally further active substances e.g. other hypotensive agents, especially Rauwolfia alkaloids, such as reserpine, rescinnamine or deserpidine, and similar compounds, such as syrosingopine, veratrum alkaloids, such as germine or protoveratrine, or above all synthetic agents acting as antihypertensives and/or diuretics, such as chlorothiazide, hydrochlorothiazide, cyclopenthiazide, or analogous compounds, 3-(3-sulphamyl-4-chlorophenyl)-3-hydroxy-isoindolin-1-one, hydralazine, dihydralazine, guanethidine, or ganglionic blockers, such as chloroisondamine.
[GB1278790A]
Patent LU-93355-B1 (LU)
Title: Inverting and switching device for micro photovoltaic power station
Inventor: WU ZHENBIAO
IPC: H02J3/38
Filed: 2016-12-13
Granted: 2017-05-31
Abstract: The present invention relates to the technical field of power control, and in particular to an inverting and switching device for a micro photovoltaic power station. The inverting and switching device for a micro photovoltaic power station comprises a DC-AC inverter module (1), a microcontroller (2), a DC-DC boost module (3) connected with a photovoltaic power generation system (a), a phase detection module (4) connected with an urban power grid (b) and a switching module (5) connected with user loads (c). According to the inverting and switching device for a micro photovoltaic power station, which is provided by the present invention, the microcontroller (2) can generate a PWM signal according to parameters, such as voltage, frequency, phase and the like, of urban power so as to control the DC-AC inverter module (1) to output a voltage signal that is synchronous with the urban power, thereby ensuring that parameters of a power supply utilized by the user loads (c) are not changed; furthermore, the microcontroller (2) can judge whether to control the switching module (5) to operate by detecting the size of the output voltage of the photovoltaic power generation system (a), thereby implementing power supply switching between the urban power grid (b) and a micro photovoltaic power grid
Patent MA-29927-B1 (MA)
Title: Dispositif de melange de fluide insere dans ou combine avec un reacteur
Inventor: BARTOLINI ANDREA
Filed: 2008-05-02
Abstract: L'invention concerne un dispositif permettant de mélanger deux fluides et qui est inséré dans ou combiné avec un réacteur, qui peut aussi être utilisé à des fins d'oxydation partielle catalytique et comprend essentiellement les deux zones suivantes: une première zone d'alimentation équipée de moyens permettant l'introduction, dans le sens axial, d'un premier fluide qui peut être gazeux dans les conditions de fonctionnement; une zone de distribution sous-jacente qui contient un faisceau de tuyaux, de préférence parallèles à l'axe à l'intérieur duquel le fluide est distribué uniformément; une deuxième zone d'alimentation équipée de moyens permettant l'introduction d'un deuxième fluide dans la zone de distribution contenant le faisceau de tuyaux de préférence parallèles et la distribution uniforme dudit fluide à l'extérieur desdits tuyaux; une zone de mélange, séparée de la zone de distribution par une plaque qui maintient les tuyaux parallèles, ladite plaque comportant des fentes ou des ouvertures permettant de décharger uniformément le deuxième fluide dans le sens axial dans la zone mélange, et lesdits tuyaux parallèles se déployant au-delà de la plaque dans la zone de mélange.